0,12% | % de acciones controlado por personas con información privilegiada |
9,41% | % de acciones controlado por instituciones |
9,42% | % de capital flotante controlado por instituciones |
94 | Número de participaciones de instituciones |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
Schroder Investment Management Group | 4.179.836 | 30 dic 2023 | 2,40% | 77.368.765 |
General Atlantic, L.P. | 4.000.000 | 30 dic 2023 | 2,30% | 74.040.000 |
Allianz Asset Management GmbH | 1.557.320 | 30 dic 2023 | 0,89% | 28.825.993 |
Bellevue Group AG | 1.131.111 | 30 dic 2023 | 0,65% | 20.936.864 |
Jane Street Group, LLC | 520.712 | 30 dic 2023 | 0,30% | 9.638.379 |
Acadian Asset Management. LLC | 488.913 | 30 dic 2023 | 0,28% | 9.049.779 |
Goldman Sachs Group Inc | 475.370 | 30 dic 2023 | 0,27% | 8.799.098 |
Aia Group Ltd | 391.278 | 30 dic 2023 | 0,22% | 7.242.555 |
Millennium Management Llc | 391.856 | 30 dic 2023 | 0,22% | 7.253.254 |
State Street Corporation | 348.770 | 30 dic 2023 | 0,20% | 6.455.732 |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
SPDR Portfolio Developed World ex-US ETF | 49.381 | 28 feb 2024 | 0,03% | 914.042 |
SSgA SPDR ETFS Europe I-SPDR MSCI Emerging Markets Small Cap UCITS ETF | 29.117 | 30 mar 2024 | 0,02% | 538.955 |
State Street Inst Inv Tr-State St All Cap Glb Equity ex-US Index Port | 21.100 | 30 dic 2023 | 0,01% | 390.561 |
Fidelity NASDAQ Composite Index Fund | 22.305 | 28 feb 2024 | 0,01% | 412.865 |
Trust For Professional Managers-PMC Diversified Equity Fund | 14.975 | 30 mar 2024 | 0,01% | 277.187 |
ETF Series Solutions-Range Cancer Therapeutics ETF | 11.212 | 28 feb 2024 | 0,01% | 207.534 |
Advisors Inner Circle Fund-Acadian Emerging Markets Port | 3.693 | 30 ene 2024 | 0,00% | 68.357 |
SEI Institutional Investment Tr-World Equity Ex-U.S. Fd | 1.061 | 28 feb 2024 | 0,00% | 19.639 |
Trust for Professional Managers-ActivePassive International Equity ETF | 8.031 | 28 feb 2024 | 0,00% | 148.653 |
ProShares Tr-Ultra Nasdaq Biotechnology Fd | 2.265 | 30 mar 2024 | 0,00% | 41.925 |